MAXIPHARMA A/S: Financial statements 2017
CVR: 87375617
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,390,449 and a net result of DKK 323,102 compared with DKK 555,720 the year before. That is a decrease of 6% compared with the year before. Equity in the 2017 report amounted to DKK 2,375,978. The solvency ratio was 65.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,390,449
- Profit/Loss
- DKK 323,102
- Equity
- DKK 2,375,978
- Total Assets
- DKK 3,650,376
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.4 mio. | 323 t. | 2.4 mio. | 2 |
| 2016 | - | 1.5 mio. | 556 t. | 2.8 mio. | 2 |
| 2015 | - | 1.2 mio. | -188 t. | 2.2 mio. | 2 |
| 2014 | - | 1.7 mio. | 508 t. | 2.6 mio. | 2 |
| 2013 | - | 973 t. | -222 t. | 2.1 mio. | - |
Keep an eye on MAXIPHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
MAXIPHARMA A/S has published its annual report for 2016. Gross profit came to DKK 1,479,629, and the net result was DKK 555,720.
About MAXIPHARMA A/S
MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The board consists of Benedikte Mailand Jensen (chair), Henrik Bencke and Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity in the 2025 report amounted to DKK 4,204,696.